HINDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Vyome Holdings, Inc
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$1.84−0.03 (-1.60%)
Close on Oct 19, 2026
- Market cap
- $12.91M
- P/E (TTM)
- –
- Dividend yield
- –
Vyome Holdings, Inc revenue by segment
By business segment
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sale of products [Member] | $103.51K | $123.38K | $174.65K | $170.55K | $227.71K | – | $134.40K | – | – | – | – | – | 79.8% | -54.5% |
| Royalty income related to above product sales [Member] | $26.22K | $29.34K | $28.17K | $57.14K | $49.88K | – | $47.40K | – | – | – | – | – | 20.2% | -47.4% |
| DBSN Device | – | – | – | – | – | – | – | $0 | $0 | $0 | $0 | – | – | – |
| Service fee for arrangements for sale of Dandruff products [Member] | – | – | – | – | – | – | $75.15K | – | – | – | – | – | – | – |
| Licensing and milestone fees Luliconazole [Member] | – | – | $116.90K | – | – | – | – | – | – | – | – | – | – | – |
By region
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | – | – | – | – | $5.63M | $6.20M | $6.89M | $6.95M | $6.67M | $6.94M | $7.13M | $8.14M | – | – |
| Australia | – | – | – | – | $333.00K | $368.00K | $392.00K | $423.00K | $451.00K | $471.00K | $526.00K | $574.00K | – | – |
| Europe | – | – | – | – | $470.00K | $587.00K | $687.00K | $764.00K | $854.00K | $849.00K | $956.00K | $998.00K | – | – |
| Rest of world | – | – | – | – | $20.00K | $20.00K | $40.00K | $45.00K | $67.00K | $75.00K | $62.00K | $95.00K | – | – |
From the segment and revenue-disaggregation notes of Vyome's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.